68 related articles for article (PubMed ID: 38503944)
21. The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer.
Mirji G; Worth A; Bhat SA; El Sayed M; Kannan T; Goldman AR; Tang HY; Liu Q; Auslander N; Dang CV; Abdel-Mohsen M; Kossenkov A; Stanger BZ; Shinde RS
Sci Immunol; 2022 Sep; 7(75):eabn0704. PubMed ID: 36083892
[TBL] [Abstract][Full Text] [Related]
22. Trimethylamine N-Oxide Promotes Cell Proliferation and Angiogenesis in Colorectal Cancer.
Yang S; Dai H; Lu Y; Li R; Gao C; Pan S
J Immunol Res; 2022; 2022():7043856. PubMed ID: 35832644
[No Abstract] [Full Text] [Related]
23. Serine biosynthesis as a novel therapeutic target for dilated cardiomyopathy.
Perea-Gil I; Seeger T; Bruyneel AAN; Termglinchan V; Monte E; Lim EW; Vadgama N; Furihata T; Gavidia AA; Arthur Ataam J; Bharucha N; Martinez-Amador N; Ameen M; Nair P; Serrano R; Kaur B; Feyen DAM; Diecke S; Snyder MP; Metallo CM; Mercola M; Karakikes I
Eur Heart J; 2022 Sep; 43(36):3477-3489. PubMed ID: 35728000
[TBL] [Abstract][Full Text] [Related]
24. Gut microbiota-derived metabolite trimethylamine-N-oxide and multiple health outcomes: an umbrella review and updated meta-analysis.
Li D; Lu Y; Yuan S; Cai X; He Y; Chen J; Wu Q; He D; Fang A; Bo Y; Song P; Bogaert D; Tsilidis K; Larsson SC; Yu H; Zhu H; Theodoratou E; Zhu Y; Li X
Am J Clin Nutr; 2022 Jul; 116(1):230-243. PubMed ID: 35348578
[TBL] [Abstract][Full Text] [Related]
25. The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer.
Wang H; Rong X; Zhao G; Zhou Y; Xiao Y; Ma D; Jin X; Wu Y; Yan Y; Yang H; Zhou Y; Qian M; Niu C; Hu X; Li DQ; Liu Q; Wen Y; Jiang YZ; Zhao C; Shao ZM
Cell Metab; 2022 Apr; 34(4):581-594.e8. PubMed ID: 35278352
[TBL] [Abstract][Full Text] [Related]
26. Cancer statistics, 2022.
Siegel RL; Miller KD; Fuchs HE; Jemal A
CA Cancer J Clin; 2022 Jan; 72(1):7-33. PubMed ID: 35020204
[TBL] [Abstract][Full Text] [Related]
27. Emerging role of trimethylamine-N-oxide (TMAO) in colorectal cancer.
Jalandra R; Dalal N; Yadav AK; Verma D; Sharma M; Singh R; Khosla A; Kumar A; Solanki PR
Appl Microbiol Biotechnol; 2021 Oct; 105(20):7651-7660. PubMed ID: 34568962
[TBL] [Abstract][Full Text] [Related]
28. Risk Factors for Thyroid Cancer: What Do We Know So Far?
Bogović Crnčić T; Ilić Tomaš M; Girotto N; Grbac Ivanković S
Acta Clin Croat; 2020 Jun; 59(Suppl 1):66-72. PubMed ID: 34219886
[TBL] [Abstract][Full Text] [Related]
29. Altered faecal microbiome and metabolome in IgG4-related sclerosing cholangitis and primary sclerosing cholangitis.
Liu Q; Li B; Li Y; Wei Y; Huang B; Liang J; You Z; Li Y; Qian Q; Wang R; Zhang J; Chen R; Lyu Z; Chen Y; Shi M; Xiao X; Wang Q; Miao Q; Fang JY; Gershwin ME; Lian M; Ma X; Tang R
Gut; 2022 May; 71(5):899-909. PubMed ID: 34035120
[TBL] [Abstract][Full Text] [Related]
30. Trimethylamine N-oxide (TMAO) in human health.
Gatarek P; Kaluzna-Czaplinska J
EXCLI J; 2021; 20():301-319. PubMed ID: 33746664
[TBL] [Abstract][Full Text] [Related]
31. Association of diet with circulating trimethylamine-N-oxide concentration.
Hamaya R; Ivey KL; Lee DH; Wang M; Li J; Franke A; Sun Q; Rimm EB
Am J Clin Nutr; 2020 Dec; 112(6):1448-1455. PubMed ID: 32936862
[TBL] [Abstract][Full Text] [Related]
32. Trimethylamine-N-oxide as One Hypothetical Link for the Relationship between Intestinal Microbiota and Cancer - Where We Are and Where Shall We Go?
Chan CWH; Law BMH; Waye MMY; Chan JYW; So WKW; Chow KM
J Cancer; 2019; 10(23):5874-5882. PubMed ID: 31737123
[TBL] [Abstract][Full Text] [Related]
33. Serum-based metabolic alterations in patients with papillary thyroid carcinoma unveiled by non-targeted 1H-NMR metabolomics approach.
Farrokhi Yekta R; Rezaei Tavirani M; Arefi Oskouie A; Mohajeri-Tehrani MR; Soroush AR; Akbarzadeh Baghban A
Iran J Basic Med Sci; 2018 Nov; 21(11):1140-1147. PubMed ID: 30483387
[TBL] [Abstract][Full Text] [Related]
34. Association of choline and betaine levels with cancer incidence and survival: A meta-analysis.
Youn J; Cho E; Lee JE
Clin Nutr; 2019 Feb; 38(1):100-109. PubMed ID: 29606601
[TBL] [Abstract][Full Text] [Related]
35. Complications following ultrasound-guided core needle biopsy of thyroid nodules: a systematic review and meta-analysis.
Ha EJ; Suh CH; Baek JH
Eur Radiol; 2018 Sep; 28(9):3848-3860. PubMed ID: 29589112
[TBL] [Abstract][Full Text] [Related]
36. Application of metabolomics in prediction of lymph node metastasis in papillary thyroid carcinoma.
Seo JW; Han K; Lee J; Kim EK; Moon HJ; Yoon JH; Park VY; Baek HM; Kwak JY
PLoS One; 2018; 13(3):e0193883. PubMed ID: 29509799
[TBL] [Abstract][Full Text] [Related]
37. European Thyroid Association Guidelines for Ultrasound Malignancy Risk Stratification of Thyroid Nodules in Adults: The EU-TIRADS.
Russ G; Bonnema SJ; Erdogan MF; Durante C; Ngu R; Leenhardt L
Eur Thyroid J; 2017 Sep; 6(5):225-237. PubMed ID: 29167761
[TBL] [Abstract][Full Text] [Related]
38. Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta-Analysis of Prospective Studies.
Heianza Y; Ma W; Manson JE; Rexrode KM; Qi L
J Am Heart Assoc; 2017 Jun; 6(7):. PubMed ID: 28663251
[TBL] [Abstract][Full Text] [Related]
39. Trimethylamine N-oxide (TMAO) as a New Potential Therapeutic Target for Insulin Resistance and Cancer.
Oellgaard J; Winther SA; Hansen TS; Rossing P; von Scholten BJ
Curr Pharm Des; 2017; 23(25):3699-3712. PubMed ID: 28641532
[TBL] [Abstract][Full Text] [Related]
40. Development of data-independent acquisition workflows for metabolomic analysis on a quadrupole-orbitrap platform.
Zhou J; Li Y; Chen X; Zhong L; Yin Y
Talanta; 2017 Mar; 164():128-136. PubMed ID: 28107906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
